Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Exanthema × Cetuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 270 Squamous Cell Carcinoma of Head and Neck 141 Head and Neck Neoplasms 123 Carcinoma, Non-Small-Cell Lung 84 Colonic Neoplasms 78 Rectal Neoplasms 71 Neoplasm Metastasis 60 Neoplasms 50 Pancreatic Neoplasms 36 Carcinoma, Squamous Cell 32 Lung Neoplasms 31 Esophageal Neoplasms 24 Breast Neoplasms 20 Stomach Neoplasms 19 Recurrence 19 Laryngeal Neoplasms 16 Mouth Neoplasms 15 Carcinoma 15 Esophageal Squamous Cell Carcinoma 14 Tongue Neoplasms 12 Adenocarcinoma Of Esophagus 12 Oropharyngeal Neoplasms 11 Hypopharyngeal Neoplasms 10 Adenocarcinoma of Lung 10 Salivary Gland Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Ovarian Neoplasms 9 Colorectal Cancer Metastatic 9 Uterine Cervical Neoplasms 8 Nasopharyngeal Carcinoma 8

Interventions

Gels 2 Fulvestrant 2 Doxycycline 2 Dapsone 2 ruxolitinib 1 dexpanthenol 1 ceterizine hydrochloride 1 capivasertib 1 benralizumab 1 Sirolimus 1 Provitamins 1 Prednisone 1 Panitumumab 1 Loperamide 1 Irinotecan 1 IFL protocol 1 Cetuximab 1 Anti-Bacterial Agents 1 Alpelisib 1 Acitretin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01315990 2013-12-18

DERMATUX

Johannes Gutenberg University Mainz

Phase 4 Unknown

Gastrointestinal

Exanthema, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡